Raloxifene Prevents Early Periprosthetic Bone Loss for Postmenopausal Women after Uncemented Total Hip Arthroplasty: A Randomized Placebo‐Controlled Clinical Trial

Raloxifene Prevents Early Periprosthetic Bone Loss for Postmenopausal Women after Uncemented Total Hip Arthroplasty: A Randomized Placebo‐Controlled Clinical Trial

Objective To examine the results of raloxifene for prevention of periprosthetic bone loss around the femoral stem in patients undergoing total hip arthroplasty (THA). Methods Between January 2015 and May 2017, 240 female patients between 55 and 80 years underwent primary THA and were randomly alloca...

Full description

Bibliographic Details
Main Authors: Long Gong, Yao‐yao Zhang, Na Yang, Huan‐juan Qian, Ling‐kun Zhang, Ming‐sheng Tan
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Orthopaedic Surgery
Subjects:
Bone loss
Postmenopausal osteoporosis
Raloxifene
Total hip arthroplasty (THA)
Online Access:https://doi.org/10.1111/os.12696

Internet

https://doi.org/10.1111/os.12696

Similar Items